M Andrulis
Overview
Explore the profile of M Andrulis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
343
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu J, Pfarr N, Endris V, Mai E, Md Hanafiah N, Lehners N, et al.
Oncogenesis
. 2017 May;
6(5):e337.
PMID: 28504689
Multiple myeloma (MM) is a plasma cell malignancy that is still considered to be incurable in most cases. A dominant mutation cluster has been identified in RAS/RAF genes, emphasizing the...
2.
Natoni A, Smith T, Keane N, McEllistrim C, Connolly C, Jha A, et al.
Leukemia
. 2017 Apr;
31(12):2642-2651.
PMID: 28439107
Multiple myeloma (MM) is characterized by the clonal expansion and metastatic spread of malignant plasma cells to multiple sites in the bone marrow (BM). Recently, we implicated the sialyltransferase ST3Gal-6,...
3.
Andrulis M
Pathologe
. 2016 Sep;
37(Suppl 2):210-216.
PMID: 27613303
The comprehensive sequencing of the complete genome of various hematological neoplasms has allowed an in-depth insight into the genomic heterogeneity and led to the discovery of new genetic aberrations, which...
4.
De novo CSF3R mutation associated with transformation of myeloproliferative neoplasm to atypical CML
Bartels S, Lehmann U, Busche G, Schlue J, Hussein K, Debatin D, et al.
Ann Hematol
. 2015 Apr;
94(7):1255-6.
PMID: 25865944
No abstract available.
5.
Dietrich S, Andrulis M, Zenz T
Internist (Berl)
. 2015 Mar;
56(4):381-90.
PMID: 25787322
Hairy cell leukemia was initially described as a distinct entity in 1958. It is rare B-cell malignancy characterized by an indolent course. Advances in the treatment and understanding of the...
6.
Goeppert B, Frauenschuh L, Zucknick M, Stenzinger A, Andrulis M, Klauschen F, et al.
Br J Cancer
. 2013 Oct;
109(10):2665-74.
PMID: 24136146
Background: Biliary tract cancers (BTC) are relatively rare malignant tumours with poor prognosis. It is known from other solid neoplasms that antitumour inflammatory response has an impact on tumour behaviour...
7.
Sander K, Sommer C, Andrulis M, Reimer P, Kreuter M, Herth F, et al.
Med Klin Intensivmed Notfmed
. 2013 Mar;
108(7):592-4.
PMID: 23494011
No abstract available.
8.
Sinn H, Andrulis M, Mogler C, Schirmacher P
Pathologe
. 2008 Oct;
29 Suppl 2:255-8.
PMID: 18843489
As with conventional microscopy, virtual microscopy permits histological tissue sections to be viewed on a computer screen with a free choice of viewing areas and a wide range of magnifications....
9.
Weigand K, Ganten T, Andrulis M, Stremmel W, Sauer P, Schaible A
Endoscopy
. 2008 Jul;
40 Suppl 2:E149.
PMID: 18633862
No abstract available.
10.
Andrulis M, Chatterjee M, Jain S, Stuhmer T, Ungethum U, Kuban R, et al.
Verh Dtsch Ges Pathol
. 2008 Mar;
91:330-7.
PMID: 18314631
HSP90's are overexpressed in different cancer types and they probably are required to sustain aberrant signalling in malignant cells. Recently, pharmacological inhibition of HSP90 was found to suppress growth of...